LncRNA	B:C1870266
MIAT	I:C1870266
enhances	O
cardiac	B:C1383860
hypertrophy	I:C1383860
partly	O
through	O
sponging	O
miR-150	B:C1537805
.	O

In	O
this	O
work	O
,	O
we	O
aimed	O
to	O
study	O
whether	O
myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
(	O
myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
)	O
exerts	O
a	O
regulative	B:C1327622
effect	O
on	O
cardiac	B:C1383860
hypertrophy	I:C1383860
via	O
acting	O
as	O
a	O
miR	B:C1537805
-150	I:C1537805
sponge	O
.	O

Cardiac	B:C1383860
hypertrophy	I:C1383860
was	O
induced	O
using	O
Angiotensin	B:C0003009
II	I:C0003009
(	O
Angiotensin	B:C0003009
II	I:C0003009
)	O
.	O

myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
and	O
miR-150	B:C1537805
expression	B:C0017262
were	O
quantified	O
using	O
qRT	B:C1514628
-	I:C1514628
PCR	I:C1514628
.	O

Rat	B:C1882687
heart	I:C1882687
-	O
derived	O
H9c2	B:C1135917
cells	I:C1135917
were	O
used	O
as	O
the	O
in	B:C1515654
vitro	I:C1515654
model	I:C1515654
.	O

Cardiac	B:C1383860
hypertrophic	I:C1383860
features	O
were	O
assessed	O
by	O
quantifying	O
cardiac	B:C1383860
hypertrophic	I:C1383860
genes	B:C0017337
and	O
measurement	O
of	O
cell	B:C0699040
surface	I:C0699040
,	O
protein	B:C0597295
synthesis	I:C0597295
and	O
total	O
protein	B:C0033684
content	O
.	O

myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
is	O
significantly	O
increased	O
in	O
Angiotensin	B:C0003009
II	I:C0003009
induced	O
cardiac	B:C1383860
hypertrophy	I:C1383860
in	O
a	O
mouse	B:C2986594
model	I:C2986594
and	O
in	O
H9c2	B:C1135917
cells	I:C1135917
.	O

myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
siRNA	B:C1099354
substantially	O
alleviated	O
the	O
Angiotensin	B:C0003009
II	I:C0003009
induced	O
upregulation	B:C0041904
of	O
ANP	B:C1417807
,	O
BNP	B:C1417808
and	O
Î²-	B:C0017337
MHC	I:C0017337
in	O
H9c2	B:C1135917
cells	I:C1135917
and	O
markedly	O
attenuated	O
the	O
Angiotensin	B:C0003009
II	I:C0003009
induced	O
increase	O
of	O
the	O
cell	B:C0699040
surface	I:C0699040
area	B:C0205146
and	O
the	O
protein	B:C0597295
synthesis	I:C0597295
.	O

myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
overexpression	B:C1514559
in	O
H9c2	B:C1135917
cells	I:C1135917
significantly	O
reduced	O
the	O
miR-150	B:C1537805
expression	B:C0017262
.	O

myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
inhibition	O
also	O
partly	O
restored	O
the	O
miR-150	B:C1537805
levels	O
under	O
Angiotensin	B:C0003009
II	I:C0003009
treatment	O
.	O

MiR	B:C1537805
-150	I:C1537805
overexpression	B:C0017262
could	O
attenuate	O
the	O
Angiotensin	B:C0003009
II	I:C0003009
induced	O
upregulation	B:C0041904
of	O
hypertrophic	B:C0020564
marker	B:C0005516
genes	B:C0017337
and	O
suppress	O
the	O
Angiotensin	B:C0003009
II	I:C0003009
induced	O
hypertrophic	B:C0020564
phenotypes	O
of	O
the	O
cells	B:C0007634
.	O

myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
is	O
significantly	O
increased	O
in	O
Angiotensin	B:C0003009
II	I:C0003009
induced	O
cardiac	B:C1383860
hypertrophy	I:C1383860
and	O
contributes	O
to	O
the	O
pathological	O
development	O
.	O

myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
can	O
suppress	O
miR-150	B:C1537805
expression	B:C0017262
in	O
cardiomyocytes	B:C0225828
and	O
miR-150	B:C1537805
is	O
a	O
downstream	O
effector	O
of	O
myocardial	B:C1870266
infarction	I:C1870266
associated	I:C1870266
transcript	I:C1870266
in	O
the	O
development	O
of	O
cardiac	B:C1383860
hypertrophy	I:C1383860
.	O

